Found: 8
Select item for more details and to access through your institution.
Weekly paclitaxel with trastuzumab and pertuzumab in patients with HER2-overexpressing metastatic breast cancer: overall survival and updated progression-free survival results from a phase II study.
- Published in:
- Breast Cancer Research & Treatment, 2016, v. 158, n. 1, p. 91, doi. 10.1007/s10549-016-3851-7
- By:
- Publication type:
- Article
A phase I trial of a single high dose of idarubicin combined with high-dose cytarabine as induction therapy in relapsed or refractory adult patients with acute lymphoblastic leukemia.
- Published in:
- 1998
- By:
- Publication type:
- journal article
Telomerase activity and telomere length in pediatric patients with malignancies undergoing chemotherapy.
- Published in:
- 1998
- By:
- Publication type:
- journal article
PHASE I STUDY OF BENDAMUSTINE, RITUXIMAB, IBRUTINIB, AND VENETOCLAX IN RELAPSED, REFRACTORY MANTLE CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2021, v. 39, p. 1, doi. 10.1002/hon.88_2881
- By:
- Publication type:
- Article
A PHASE I STUDY OF IBRUTINIB COMBINED WITH RITUXIMAB, IFOSFAMIDE, CARBOPLATIN, AND ETOPOSIDE IN PATIENTS WITH RELAPSED OR PRIMARY REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 265, doi. 10.1002/hon.2438_135
- By:
- Publication type:
- Article
A PILOT STUDY OF BRENTUXIMAB VEDOTIN AND AVD CHEMOTHERAPY FOLLOWED BY 20 GY INVOLVED-SITE RADIOTHERAPY IN EARLY STAGE, UNFAVORABLE RISK HODGKIN LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 171, doi. 10.1002/hon.2438_30
- By:
- Publication type:
- Article
PHASE I/IB DOSE ESCALATION AND EXPANSION OF IBRUTINIB AND BUPARLISIB IN RELAPSED/REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA, MANTLE CELL LYMPHOMA, AND FOLLICULAR LYMPHOMA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 54, doi. 10.1002/hon.2437_38
- By:
- Publication type:
- Article
DEFINING PROGRESSION FREE SURVIVAL AFTER MULTIPLE LINES OF THERAPY AND IMPACT OF DYNAMIC CHANGES IN FLIPI FOR MULTIPLY RELAPSED FOLLICULAR LYMPHOMA IN THE RITUXIMAB ERA.
- Published in:
- Hematological Oncology, 2017, v. 35, p. 229, doi. 10.1002/hon.2438_92
- By:
- Publication type:
- Article